| NCT03329391 |
Psychosocial Characteristics and Non-pharmacological Intervention of Patients With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT03329391 |
Recruiting |
National Taiwan University Hospital |
2019-10-17 |
| NCT03288675 |
Stepped Care aiTBS 2 Depression Study (Ghent) |
https://ClinicalTrials.gov/show/NCT03288675 |
Recruiting |
University Hospital, Ghent |
2022-12-31 |
| NCT03283670 |
Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies |
https://ClinicalTrials.gov/show/NCT03283670 |
Completed |
Washington University School of Medicine |
2020-02-18 |
| NCT03272698 |
ECT With Ketamine Anesthesia vs High Intensity Ketamine With ECT Rescue for Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT03272698 |
Recruiting |
University of Saskatchewan |
2021-06-30 |
| NCT03257397 |
TBS in Major Depression |
https://ClinicalTrials.gov/show/NCT03257397 |
Recruiting |
Medical University of Vienna |
2020-07-31 |
| NCT03240692 |
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression: OL Cohort |
https://ClinicalTrials.gov/show/NCT03240692 |
Active, not recruiting |
Stanford University |
2020-05-01 |
| NCT03191058 |
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression |
https://ClinicalTrials.gov/show/NCT03191058 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2022-07-31 |
| NCT03149991 |
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) |
https://ClinicalTrials.gov/show/NCT03149991 |
Completed |
Massachusetts General Hospital |
2019-03-31 |
| NCT03113968 |
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) |
https://ClinicalTrials.gov/show/NCT03113968 |
Active, not recruiting |
The Cleveland Clinic |
2021-03-01 |
| NCT03105700 |
Low Frequency TMS for Depression in Epilepsy |
https://ClinicalTrials.gov/show/NCT03105700 |
Recruiting |
Dartmouth-Hitchcock Medical Center |
2020-10-31 |
| NCT03068715 |
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD) |
https://ClinicalTrials.gov/show/NCT03068715 |
Active, not recruiting |
Stanford University |
2020-01-25 |
| NCT03051256 |
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder |
https://ClinicalTrials.gov/show/NCT03051256 |
Completed |
Relmada Therapeutics, Inc. |
2019-07-29 |
| NCT03027362 |
Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT03027362 |
Completed |
Yale University |
2019-09-30 |
| NCT03004521 |
Lithium Versus Quetiapine in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT03004521 |
Recruiting |
King’s College London |
2020-07-31 |
| NCT02994433 |
NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits |
https://ClinicalTrials.gov/show/NCT02994433 |
Active, not recruiting |
Washington University School of Medicine |
2020-08-31 |
| NCT02974296 |
Neuroimaging in Patients Undergoing TMS for Depression |
https://ClinicalTrials.gov/show/NCT02974296 |
Completed |
New York State Psychiatric Institute |
2019-08-20 |
| NCT02971150 |
Treatment Resistant Depression and Insomnia in Older Veterans |
https://ClinicalTrials.gov/show/NCT02971150 |
Completed |
VA Pittsburgh Healthcare System |
2017-03-31 |
| NCT02960763 |
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults |
https://ClinicalTrials.gov/show/NCT02960763 |
Active, not recruiting |
Washington University School of Medicine |
2021-09-30 |
| NCT02942368 |
Adaptive tDCS for Treatment-Resistant MDD |
https://ClinicalTrials.gov/show/NCT02942368 |
Active, not recruiting |
Washington University School of Medicine |
2021-06-30 |
| NCT02935595 |
Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients |
https://ClinicalTrials.gov/show/NCT02935595 |
Active, not recruiting |
The University of Texas Health Science Center, Houston |
2019-09-30 |
| NCT02922725 |
Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females |
https://ClinicalTrials.gov/show/NCT02922725 |
Recruiting |
University of Utah |
2020-07-31 |
| NCT02918318 |
A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT02918318 |
Completed |
Janssen Pharmaceutical K.K. |
2019-08-19 |
| NCT02914769 |
Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT02914769 |
Completed |
Universidade Federal do Rio Grande do Norte |
2016-12-31 |
| NCT02911597 |
Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD) |
https://ClinicalTrials.gov/show/NCT02911597 |
Completed |
Stanford University |
2018-02-28 |
| NCT02900092 |
Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone |
https://ClinicalTrials.gov/show/NCT02900092 |
Completed |
Massachusetts General Hospital |
2018-01-12 |
| NCT02810717 |
Effects of TBS on 5-HT1A Receptor Binding |
https://ClinicalTrials.gov/show/NCT02810717 |
Recruiting |
Medical University of Vienna |
2019-11-30 |
| NCT02782104 |
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02782104 |
Recruiting |
Janssen Research & Development, LLC |
2021-08-06 |
| NCT02611206 |
Repetitive Transcranial Magnetic Stimulation for Adolescent Depression: Efficacy, Predictive Biomarkers, and Mechanisms |
https://ClinicalTrials.gov/show/NCT02611206 |
Recruiting |
University of Minnesota |
2020-06-30 |
| NCT02577250 |
Ketamine Infusions for PTSD and Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT02577250 |
Completed |
Minneapolis Veterans Affairs Medical Center |
2016-06-30 |
| NCT02522377 |
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT02522377 |
Completed |
The Cleveland Clinic |
2018-03-01 |
| NCT02497287 |
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02497287 |
Completed |
Janssen Research & Development, LLC |
2017-10-28 |
| NCT02493868 |
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02493868 |
Completed |
Janssen Research & Development, LLC |
2018-02-15 |
| NCT02456948 |
Adjunct Minocyline in Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02456948 |
Active, not recruiting |
Charite University, Berlin, Germany |
2020-02-29 |
| NCT02452892 |
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) |
https://ClinicalTrials.gov/show/NCT02452892 |
Completed |
Tal Medical, Inc. |
2016-09-30 |
| NCT02422186 |
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02422186 |
Completed |
Janssen Research & Development, LLC |
2017-08-10 |
| NCT02418585 |
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02418585 |
Completed |
Janssen Research & Development, LLC |
2017-06-01 |
| NCT02417064 |
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02417064 |
Completed |
Janssen Research & Development, LLC |
2018-02-20 |
| NCT02360280 |
Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02360280 |
Completed |
VA Office of Research and Development |
2018-10-22 |
| NCT02356107 |
5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females |
https://ClinicalTrials.gov/show/NCT02356107 |
Completed |
University of Utah |
2016-08-31 |
| NCT02263872 |
Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT02263872 |
Completed |
Pakistan Institute of Living and Learning |
2016-06-30 |
| NCT02153502 |
Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment |
https://ClinicalTrials.gov/show/NCT02153502 |
Completed |
Avanir Pharmaceuticals |
2016-02-29 |
| NCT02150577 |
Implementation Trial of Evidence Based Practices for Mood Disorders |
https://ClinicalTrials.gov/show/NCT02150577 |
Completed |
University of Arkansas |
2017-11-01 |
| NCT02141776 |
Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT02141776 |
Completed |
University of Florida |
2018-01-08 |
| NCT02080507 |
rTMS in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT02080507 |
Completed |
Emory University |
2015-12-31 |
| NCT02078817 |
Ketamine in Adolescents With Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT02078817 |
Completed |
University of Minnesota |
2018-03-31 |
| NCT01304147 |
Intranasal Ketamine in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT01304147 |
Completed |
Icahn School of Medicine at Mount Sinai |
2014-10-31 |
| NCT01282632 |
Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01282632 |
Completed |
Sunnybrook Health Sciences Centre |
2004-03-31 |
| NCT02046330 |
Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT02046330 |
Recruiting |
The University of Texas Health Science Center, Houston |
2022-11-30 |
| NCT02556606 |
Ketamine for Treatment Resistant Late-Life Depression |
https://ClinicalTrials.gov/show/NCT02556606 |
Active, not recruiting |
VA Office of Research and Development |
2020-03-31 |
| NCT01998958 |
A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT01998958 |
Completed |
Janssen Research & Development, LLC |
2015-07-21 |
| NCT01984710 |
DBS for TRD Medtronic Activa PC+S |
https://ClinicalTrials.gov/show/NCT01984710 |
Active, not recruiting |
Emory University |
2023-09-30 |
| NCT01983904 |
DBS for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01983904 |
Completed |
University of Calgary |
2017-12-31 |
| NCT01973478 |
Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01973478 |
Completed |
Rennes University Hospital |
2017-07-03 |
| NCT01945047 |
Action of Ketamine in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT01945047 |
Completed |
University of Ottawa |
2017-12-31 |
| NCT01944644 |
Low Field Magnetic Stimulation for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01944644 |
Completed |
Weill Medical College of Cornell University |
2016-05-31 |
| NCT01935115 |
Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy |
https://ClinicalTrials.gov/show/NCT01935115 |
Completed |
University of Saskatchewan |
2016-03-31 |
| NCT01920555 |
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) |
https://ClinicalTrials.gov/show/NCT01920555 |
Completed |
Massachusetts General Hospital |
2017-01-31 |
| NCT01898429 |
Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD) |
https://ClinicalTrials.gov/show/NCT01898429 |
Completed |
Dartmouth-Hitchcock Medical Center |
2016-12-31 |
| NCT01880593 |
Ketamine Plus Lithium in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT01880593 |
Completed |
Icahn School of Medicine at Mount Sinai |
2016-11-30 |
| NCT01798407 |
DBS of the Lateral Habenula in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT01798407 |
Active, not recruiting |
Baylor College of Medicine |
2020-08-31 |
| NCT01677078 |
Coupling Repetitive Transcranial Magnetic Stimulation With a Neuronavigation System in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01677078 |
Completed |
Rennes University Hospital |
2017-03-25 |
| NCT01654796 |
Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT01654796 |
Completed |
Massachusetts General Hospital |
2016-05-31 |
| NCT01640080 |
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT01640080 |
Completed |
Janssen Research & Development, LLC |
2013-06-03 |
| NCT01597167 |
Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01597167 |
Completed |
University of Miami |
2014-12-31 |
| NCT01596608 |
Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder |
https://ClinicalTrials.gov/show/NCT01596608 |
Completed |
Centre for Addiction and Mental Health |
2019-06-30 |
| NCT01515215 |
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder |
https://ClinicalTrials.gov/show/NCT01515215 |
Completed |
Centre for Addiction and Mental Health |
2016-10-31 |
| NCT01507155 |
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay |
https://ClinicalTrials.gov/show/NCT01507155 |
Completed |
Genomind, LLC |
2014-05-31 |
| NCT01407575 |
Buprenorphine for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01407575 |
Completed |
University of Pittsburgh |
2013-08-31 |
| NCT01383811 |
Exercise in Treatment Resistant Depression (TRD): A Feasibility Study |
https://ClinicalTrials.gov/show/NCT01383811 |
Completed |
Milton S. Hershey Medical Center |
2013-06-30 |
| NCT01353092 |
Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01353092 |
Completed |
Hillerod Hospital, Denmark |
2013-06-30 |
| NCT04428099 |
Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression |
https://ClinicalTrials.gov/show/NCT04428099 |
Recruiting |
University of the Balearic Islands |
2022-01-12 |
| NCT04226352 |
Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder |
https://ClinicalTrials.gov/show/NCT04226352 |
Recruiting |
Johns Hopkins University |
2020-12-31 |
| NCT04216888 |
Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine |
https://ClinicalTrials.gov/show/NCT04216888 |
Recruiting |
Nathan Kline Institute for Psychiatric Research |
2020-06-30 |
| NCT04202770 |
Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias |
https://ClinicalTrials.gov/show/NCT04202770 |
Enrolling by invitation |
Neurological Associates of West Los Angeles |
2021-12-31 |
| NCT04199143 |
Brain Reactivity to Nitrous Oxyde in Depression : an MRI and Ultrasound Study (PROTOBRAIN Pilote) |
https://ClinicalTrials.gov/show/NCT04199143 |
Recruiting |
University Hospital, Tours |
2021-09-30 |
| NCT04159285 |
Psychotherapeutic Augmentation of Brain Stimulation Effects |
https://ClinicalTrials.gov/show/NCT04159285 |
Recruiting |
Charite University, Berlin, Germany |
2020-06-15 |
| NCT04153812 |
Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression |
https://ClinicalTrials.gov/show/NCT04153812 |
Recruiting |
Xijing Hospital |
2021-10-01 |
| NCT04106466 |
DBS for TRD With the Medtronic Summit RC+S |
https://ClinicalTrials.gov/show/NCT04106466 |
Active, not recruiting |
Icahn School of Medicine at Mount Sinai |
2023-12-31 |
| NCT04076124 |
Brain-derived Neurotrophic Factor and the Antidepressant Efficacy of Brain Stimulation |
https://ClinicalTrials.gov/show/NCT04076124 |
Recruiting |
Taipei Veterans General Hospital, Taiwan |
2021-09-30 |
| NCT04039022 |
Open-Label Safety Study of AXS-05 in Subjects With Depression |
https://ClinicalTrials.gov/show/NCT04039022 |
Recruiting |
Axsome Therapeutics, Inc. |
2020-07-31 |
| NCT04037592 |
Dorsomedial Prefrontal Cortex and the Antidepressant Efficacy of Theta Burst Stimulation in Depressed Patients |
https://ClinicalTrials.gov/show/NCT04037592 |
Recruiting |
Taipei Veterans General Hospital, Taiwan |
2020-12-31 |
| NCT04009928 |
Deep Brain Stimulation for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT04009928 |
Recruiting |
Sunnybrook Health Sciences Centre |
2022-01-31 |
| NCT03991572 |
rTMS Intervention on Motivational Anhedonia of Treatment Resistant Depression and Brian Network Mechanism |
https://ClinicalTrials.gov/show/NCT03991572 |
Recruiting |
Anhui Medical University |
2021-12-31 |
| NCT03965858 |
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT03965858 |
Completed |
Celon Pharma SA |
2020-03-15 |
| NCT03952962 |
Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT03952962 |
Recruiting |
University of California, Los Angeles |
2024-07-31 |
| NCT03932825 |
Nitrous Oxide for Major Depressive Disorder |
https://ClinicalTrials.gov/show/NCT03932825 |
Recruiting |
Central South University |
2020-08-31 |
| NCT03887715 |
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT03887715 |
Recruiting |
LivaNova |
2022-08-31 |
| NCT03887624 |
Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression. |
https://ClinicalTrials.gov/show/NCT03887624 |
Recruiting |
Zhejiang University |
2020-04-30 |
| NCT03786614 |
Antidepressant Discontinuation in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT03786614 |
Recruiting |
University of Louisville |
2021-04-30 |
| NCT03775200 |
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT03775200 |
Recruiting |
COMPASS Pathways |
2020-08-31 |
| NCT03756129 |
Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT03756129 |
Completed |
Novartis |
2020-03-23 |
| NCT03742557 |
Evaluation of Schemes of Administration of Intravenous Ketamine in Depression |
https://ClinicalTrials.gov/show/NCT03742557 |
Recruiting |
National Institute of Neurology and Neurosurgery, Mexico |
2020-01-01 |
| NCT03701724 |
Cost-utility Analysis of Maintenance rTMS for Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT03701724 |
Recruiting |
Nantes University Hospital |
2021-10-15 |
| NCT03684447 |
Neural and Antidepressant Effects of Propofol |
https://ClinicalTrials.gov/show/NCT03684447 |
Recruiting |
University of Utah |
2024-03-31 |
| NCT03680781 |
Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study |
https://ClinicalTrials.gov/show/NCT03680781 |
Enrolling by invitation |
Stanford University |
2022-12-31 |
| NCT03653858 |
Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression |
https://ClinicalTrials.gov/show/NCT03653858 |
Recruiting |
University Hospital Freiburg |
2022-06-02 |
| NCT03642522 |
Investigating Predictors of Treatment Response in Treatment-Resistant Depression (TRD) With Interleaved TMS/fMRI |
https://ClinicalTrials.gov/show/NCT03642522 |
Recruiting |
University of British Columbia |
2019-12-31 |
| NCT03626181 |
Biomarkers of Theta Burst Stimulation in Major Depressive Disorder |
https://ClinicalTrials.gov/show/NCT03626181 |
Recruiting |
University of Calgary |
2019-07-01 |
| NCT03606395 |
Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT03606395 |
Completed |
Navitor Pharmaceuticals, Inc. |
2019-06-09 |
| NCT03573349 |
Glutamate MRS During Ketamine Infusion |
https://ClinicalTrials.gov/show/NCT03573349 |
Enrolling by invitation |
Mayo Clinic |
2021-08-31 |
| NCT03564041 |
SSM vs HEP in Late-Life Depression |
https://ClinicalTrials.gov/show/NCT03564041 |
Recruiting |
Lawson Health Research Institute |
2021-08-31 |
| NCT03435744 |
Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial. |
https://ClinicalTrials.gov/show/NCT03435744 |
Recruiting |
Pakistan Institute of Living and Learning |
2020-12-31 |
| NCT03434041 |
A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT03434041 |
Recruiting |
Janssen Research & Development, LLC |
2021-04-28 |
| NCT03428828 |
Neurofeedback for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT03428828 |
Recruiting |
University of Pittsburgh |
2023-03-01 |
| NCT01246908 |
Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01246908 |
Completed |
CeNeRx BioPharma Inc. |
2012-05-31 |
| NCT01204918 |
Efficacy and Tolerability of Riluzole in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01204918 |
Completed |
Yale University |
2015-05-31 |
| NCT01179009 |
Treatment Resistant Depression (Pilot) |
https://ClinicalTrials.gov/show/NCT01179009 |
Active, not recruiting |
Washington University School of Medicine |
2020-06-30 |
| NCT01071538 |
Buprenorphine for Late-Life Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT01071538 |
Completed |
University of Pittsburgh |
2012-05-31 |
| NCT00958568 |
A Study in Relapse Prevention of Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT00958568 |
Completed |
Eli Lilly and Company |
2012-03-31 |
| NCT00953745 |
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT00953745 |
Completed |
Washington University School of Medicine |
2012-06-30 |
| NCT00837486 |
Reclaim Deep Brain Stimulation Clinical Study for Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT00837486 |
Completed |
MedtronicNeuro |
2010-12-31 |
| NCT03711019 |
Efficacy of Convulsive Therapies During Continuation |
https://ClinicalTrials.gov/show/NCT03711019 |
Recruiting |
Centre for Addiction and Mental Health |
2021-09-30 |
| NCT03152409 |
Salicylic Augmentation in Depression |
https://ClinicalTrials.gov/show/NCT03152409 |
Recruiting |
Brigham and Women’s Hospital |
2020-07-31 |
| NCT00809562 |
A Study of RO4917523 in Patients With Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT00809562 |
Completed |
Hoffmann-La Roche |
2011-02-28 |
| NCT00808938 |
A Pilot Study of the Use of Magnetic Seizure Therapy for Depression |
https://ClinicalTrials.gov/show/NCT00808938 |
Completed |
Bayside Health |
2011-01-31 |
| NCT01627782 |
A Study of Ketamine in Patients With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT01627782 |
Completed |
Janssen Research & Development, LLC |
2013-09-12 |
| NCT03953417 |
Bilateral Accelerated Theta Burst in Treatment-Resistant Bipolar Depression |
https://ClinicalTrials.gov/show/NCT03953417 |
Recruiting |
Stanford University |
2021-07-01 |
| NCT00789854 |
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients |
https://ClinicalTrials.gov/show/NCT00789854 |
Completed |
AstraZeneca |
2009-08-31 |
| NCT00768430 |
Optimization of IV Ketamine for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT00768430 |
Completed |
Baylor College of Medicine |
2012-09-30 |
| NCT00704860 |
Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism |
https://ClinicalTrials.gov/show/NCT00704860 |
Completed |
University of Ottawa |
2009-11-30 |
| NCT00667680 |
Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT00667680 |
Completed |
Ludwig-Maximilians - University of Munich |
2008-09-30 |
| NCT00664976 |
Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy |
https://ClinicalTrials.gov/show/NCT00664976 |
Completed |
Norwegian University of Science and Technology |
2011-05-31 |
| NCT00608543 |
Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression |
https://ClinicalTrials.gov/show/NCT00608543 |
Completed |
University of Texas Southwestern Medical Center |
2009-01-31 |
| NCT00565617 |
Epidural Cortical Stimulation for Depression |
https://ClinicalTrials.gov/show/NCT00565617 |
Active, not recruiting |
Medical University of South Carolina |
2009-12-31 |
| NCT00531726 |
Berlin Deep Brain Stimulation Depression Study |
https://ClinicalTrials.gov/show/NCT00531726 |
Completed |
Charite University, Berlin, Germany |
2012-09-30 |
| NCT00367003 |
Deep Brain Stimulation for Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT00367003 |
Recruiting |
Emory University |
2024-11-30 |
| NCT00305565 |
Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses |
https://ClinicalTrials.gov/show/NCT00305565 |
Completed |
Cyberonics, Inc. |
2010-02-28 |
| NCT00253266 |
Venlafaxine Augmentation in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT00253266 |
Completed |
Max-Planck-Institute of Psychiatry |
2014-04-30 |
| NCT00186056 |
Mifepristone in Refractory Depression |
https://ClinicalTrials.gov/show/NCT00186056 |
Completed |
Stanford University |
2007-05-31 |
| NCT00179244 |
Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT00179244 |
Completed |
Vanderbilt University |
NA |
| NCT00093847 |
Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression |
https://ClinicalTrials.gov/show/NCT00093847 |
Completed |
Massachusetts General Hospital |
2009-02-28 |
| NCT00070694 |
An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT00070694 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00044681 |
A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression |
https://ClinicalTrials.gov/show/NCT00044681 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00035321 |
The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression |
https://ClinicalTrials.gov/show/NCT00035321 |
Completed |
Eli Lilly and Company |
NA |